Perfil
Yi Liu was the founder of Kura Oncology, Inc. (2014, Chief Scientific Officer), Intellikine LLC (2007, Vice President-Drug Discovery), and Kumquat Biosciences, Inc. (2018, Chief Executive Officer & Director).
Former jobs include Principal at CuraGen Corp., Chief Scientific Officer at Zeta Acquisition Corp.
III, Principal at SGX Pharmaceuticals, Inc., Head-Drug Design Group at Novartis Institute for Functional Genomics, Inc., and Chief Scientific Officer at Wellspring Biosciences LLC (2012-2014).
Education includes a doctorate from Princeton University, an undergraduate degree from Tsinghua University, and a graduate degree from Beijing University of Technology.
Cargos activos de Yi Liu
| Empresas | Cargo | Inicio |
|---|---|---|
Kumquat Biosciences, Inc.
Kumquat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Fundador | 01/11/2018 |
Antiguos cargos conocidos de Yi Liu.
| Empresas | Cargo | Fin |
|---|---|---|
Wellspring Biosciences LLC
Wellspring Biosciences LLC Pharmaceuticals: MajorHealth Technology Discovers and develops molecule drugs targeting signal transduction networks for the treatment of cancer and other diseases | Director Técnico/Científico/I+D | 01/09/2014 |
Intellikine LLC
Intellikine LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs for the treatment of cancer | Fundador | 01/05/2012 |
Zeta Acquisition Corp. III
Zeta Acquisition Corp. III MiscellaneousMiscellaneous Operates as a blank check company | Director Técnico/Científico/I+D | - |
| KURA ONCOLOGY, INC. | Fundador | - |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Corporate Officer/Principal | - |
Formación de Yi Liu.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 11 |
|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
Zeta Acquisition Corp. III
Zeta Acquisition Corp. III MiscellaneousMiscellaneous Operates as a blank check company | Miscellaneous |
Kura Oncology, Inc.
Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
SGX Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops drugs and other pharmaceutical products | Health Technology |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tsinghua University
Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institute for Functional Genomics, Inc.
Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts research related to biotechnology and medicine | Commercial Services |
Intellikine LLC
Intellikine LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures small molecule drugs for the treatment of cancer | Health Technology |
Beijing University of Technology
Beijing University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wellspring Biosciences LLC
Wellspring Biosciences LLC Pharmaceuticals: MajorHealth Technology Discovers and develops molecule drugs targeting signal transduction networks for the treatment of cancer and other diseases | Health Technology |
Kumquat Biosciences, Inc.
Kumquat Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics | Health Technology |
- Bolsa de valores
- Insiders
- Yi Liu
















